Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows.
Led by researchers at NYU Langone Health and its Perlmutter Cancer Center, the study showed that approximately 80% of stage III melanoma patients who had…